Our Products
We are leaders in the market for providing best range of Nivolumab, Forteo, Bevacizumab, Eribulin and Cyclophosphamide
forteo 600 mcg injection
this is solution for injection in a pre-filled pen. Subcutaneous (sc) use. * 1 pen of 2.4 ml solution. Each pen contains 28 doses of 20 micrograms (per 80 microliters).
BEVACIZUMAB is a monoclonal antibody. It is used to treat cervical cancer, colorectal cancer, glioblastoma multiforme, non-small cell lung cancer (NSCLC), ovarian cancer, and renal cell cancer.